» Articles » PMID: 22946918

Dried Matrix on Paper Disks: the Next Generation DBS Microsampling Technique for Managing the Hematocrit Effect in DBS Analysis

Overview
Journal Bioanalysis
Specialty Chemistry
Date 2012 Sep 6
PMID 22946918
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The hematocrit effect is a hurdle for successful introduction of the dried blood spot (DBS) in a regulated environment. Recently, attempts were taken to overcome the hematocrit effect by whole-cut DBS analysis. This paper presents the next-generation whole-cut DBS; dried matrix on paper disks (DMPD).

Results: DMPD eliminated the hematocrit effect and demonstrated better accuracy and precision than regular DBS with partial punching. Observed accuracy and precision were 6.0 and 2.3% for DMPD, respectively, and -10.4 and 17.1%, for DBS, respectively.

Conclusion: The DMPD technique performed better than regular DBS by eliminating the hematocrit effect related blood volume bias. Although this effect was not observed with DMPD, a systematic error of 6.0% was detected and further technical development of DMPD could improve the performance.

Citing Articles

Direct multi-elemental analysis of cerebrospinal fluid samples by LA-ICP-MS employing an aerosol local extraction cryogenic ablation cell.

Li F, Cui H, Zhang D, Li H, Guo W, Jin L Anal Bioanal Chem. 2023; 415(24):6051-6061.

PMID: 37541973 DOI: 10.1007/s00216-023-04878-2.


Clinical validation of a liquid chromatography-tandem mass spectrometry method for the quantification of calcineurin and mTOR inhibitors in dried matrix on paper discs.

Bressan I, Gimenez M, Llesuy S J Mass Spectrom Adv Clin Lab. 2022; 25:12-18.

PMID: 35694178 PMC: 9184858. DOI: 10.1016/j.jmsacl.2022.06.002.


Validation of a simple liquid chromatography coupled to tandem mass spectrometry method for the simultaneous determination of tacrolimus, sirolimus, everolimus and cyclosporin A in dried matrix on paper discs.

Bressan I, Gimenez M, Llesuy S J Mass Spectrom Adv Clin Lab. 2021; 19:7-19.

PMID: 34820661 PMC: 8601012. DOI: 10.1016/j.jmsacl.2021.01.003.


Advantages and Challenges of Dried Blood Spot Analysis by Mass Spectrometry Across the Total Testing Process.

Zakaria R, Allen K, Koplin J, Roche P, Greaves R EJIFCC. 2017; 27(4):288-317.

PMID: 28149263 PMC: 5282914.


Implementing dried blood spot sampling for clinical pharmacokinetic determinations: considerations from the IQ Consortium Microsampling Working Group.

Evans C, Arnold M, Bryan P, Duggan J, James C, Li W AAPS J. 2014; 17(2):292-300.

PMID: 25488054 PMC: 4365086. DOI: 10.1208/s12248-014-9695-3.